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Summary. Intranasal administration of norethisterone at a daily dose of 9 \g=m\gbetween
Days 5 and 14 of the menstrual cycles blocked ovulation in 10 out of 17 adult female
monkeys. Serum concentrations of hormones indicated that ovulation was blocked due
to a suppression of the mid-cycle, oestradiol-induced LH surge. Ovarian follicular
activity in the treated menstrual cycles was not affected by norethisterone but there was
a marked delay in the onset of the mid-cycle oestradiol surge in most of the treated
animals. The duration of the menstrual cycle length after the oestradiol peak was
significantly reduced in all the treated monkeys, indicative of a shortened luteal phase.
Introduction
The bioavailability of steroids is significantly enhanced when administered intranasally as
compared with their systemic administration (Anand Kumar, David, Umberkoman & Saini, 1974;
Anand Kumar, David, Sankaranarayanan, Puri & Sundaram, 1982). The difference in the
pharmacokinetic patterns between the two routes of administration has been related to the dif¬
ferent pathways and the rates at which the steroid enters the general circulation from the site of
administration (Anand Kumar et al., 1982). As a consequence of the increased bioavailability, the
intranasal route offers a potential advantage over the conventionally used oral or systemic routes in
terms of lowering the dose of the administered steroids without concomitant reduction in their
pharmacological efficacy (Anand Kumar, David, Kumar, Umberkoman & Krishnamoorthy,
1976). Such an advantage could be exploited in the administration of contraceptive steroids which
are currently being used by a large number of individuals quite extensively. Studies on the efficacy
of steroids administered intranasally have been undertaken with female (Anand Kumar, David &
Puri, 1977) and male (Anand Kumar, Sehgal, David, Bajaj & Prasad, 1980a) rhesus monkeys. The
ability of norethisterone to inhibit ovulation was the only criterion used to evaluate the efficacy of
the intranasal route and these studies showed that ovulation was not uniformly inhibited (Anand
Kumar et al., 1977). A more comprehensive study carried out recently on women treated with a
minipill of 300 µg norethisterone by Landgren & Diczfalusy (1980) showed that inhibition of
ovulation is not the only way in which the steroid acts; there was inhibition of follicular and luteal
activities, occurrence of normal follicular activity but absence of luteal function, poor luteal
function and some women did not show any differences in their ovarian activities.
In the present investigations with rhesus monkeys, the effects of norethisterone were studied
with particular reference to circulating concentrations of oestradiol and progesterone in blood sam¬
ples taken throughout the treatment menstrual cycle and concentrations of bioactive luteinizing
hormone (LH) on the days around the mid-cycle oestradiol peak.
* Reprint requests to Dr T. C. Anand Kumar.
t Present address: WHO-CCR, Institute for Research in Reproduction, Parel, Bombay 400 012, India.
Materials and Methods
Animals. Healthy parous, female rhesus monkeys (N = 27), each weighing 5-6 kg, were taken from
the Primate Research Facility of the Institute. The studies were carried out between September and
April when the incidence of ovulatory menstrual cycles is maximal in this colony (Anand Kumar et
al., 1980b). Only animals exhibiting at least two consecutive ovulatory menstrual cycles of normal
duration (23-31 days), as determined by laparoscopy and examination of daily vaginal smears,
were taken for the studies.
Reagents. All the reagents used were of analytical grade. Norethisterone (Steraloids, Inc.,
Wilton, NH, U.S.A.), oestradiol and progesterone (Sigma Chemicals, St Louis, MO, U.S.A.)
were used without further purification. The trititum-labelled steroids were obtained from the
Radiochemical Centre, Amersham, U.K., and were checked for their radiochemical purity by
thin-layer chromatography before use.
The antisera for oestradiol, progesterone and testosterone were supplied by the World Health
Organization under their quality control programme for radioimmunoassay methods (Hall, 1978).
Rhesus monkey pituitary extract (LER-1909-2; National Institutes of Health, U.S.A.) was used as
the reference standard for estimating LH.
Treatment. Norethisterone was dissolved in a solution of propylene glycol:ethanol:water (3:3:4
by vol.) and was sprayed intranasally using a precalibrated glass atomizer as described previously(Gopinath, Gopinath & Anand Kumar, 1978; Anand Kumar et al., 1979). The animals were
treated between 10:00 and 11:00 h with nasal sprays on Days 5-14 (Day 1 is the first day of
menstruation) of the menstrual cycle. The control monkeys (N = 10) were sprayed with the solvent
only whereas the experimental animals (N = 17) were sprayed with a daily dose of 9µg
norethisterone.
Monitoring ofmenstrual cycles. The length of the menstrual cycle and duration of menses were
monitored by daily microscopic examination of vaginal smears.
Laparoscopy. The animals were sedated with ketamine hydrochloride (10 mg/kg body weight,
i.m.) and laparoscopy was performed on Day 20 of the menstrual cycle during the pretreatment and
treatment cycles to determine whether ovulation had occurred, as indicated by the presence of a
newly formed corpus luteum.
Collection of blood samples. Blood samples (5 ml each) were taken by syringe from the
saphenous vein daily throughout the menstrual cycles, between 10:00 and 11:00 h before treatment.
Serum was separated and stored at
—
20°C until assayed for various hormones.
Assay of hormones. Concentrations of oestradiol and progesterone in the serum samples were
measured by specific radioimmunoassay (RIA) methods (Anand Kumar et al., 1980c). The sensi¬
tivities of the assays were 10 pmol/1 for oestradiol and 15 pmol/1 for progesterone. The coefficients
of variation within and between assays in the present study were 3-2% and 709% for oestradiol(N = 25) and 3-8% and 6-3% for progesterone (N= 30), respectively. Concentrations ofLH were
estimated by an in-vitro bioassay method using Leydig cells from mouse testes (Puri, Puri, David &
Anand Kumar, 1980). LH was measured in every sample taken from the solvent-treated controls,
but only in those taken 2 days before, on the day of and 2 days after the mid-cycle oestradiol peak
in the norethisterone-treated females. The sensitivity of the LH assay was 2ng LER-1909-2
equiv./tube and the coefficients of variation within and between assays were 9-3% and 11-3%(N = 19) respectively.
The RIA data were analysed by logit-log transformation to obtain a linear dose-response curve,
followed by unweighted or weighted least square regression analysis using a Hewlett-Packard
calculator (Model 9831).
Evaluation ofendocrine effects. The most consistent endocrine feature of all the menstrual cycles
studied was the occurrence of the 'mid-cycle' preovulatory oestradiol peak; this was taken as the
cardinal point to divide the menstrual cycle into two phases. Phase I included Day 1 of menstru¬
ation upto and inclusive of the day of the 'mid-cycle' oestradiol peak. Phase II included the day
after the oestradiol peak to the penultimate day of the ensuing menstruation. These two phases are
not synonymous with the follicular and luteal phases of the cycle because ovulation is known to
occur in monkeys 36-40 h (Weick et al., 1973) after the oestradiol-induced LH surge and therefore
Phase II of the menstrual cycle would also include a small part of the follicular phase.
Statistical test. The mean oestradiol peak values at mid-cycle and the mean progesterone
concentrations during Phase II of the menstrual cycles of controls and norethisterone-treated
monkeys were compared by Student's paired t test. The concentration ofLH on the 2 days before,
on the day of and on 2 days after the 'mid-cycle' oestradiol peak were also similarly compared by
Student's paired / test. The day of the mid-cycle oestradiol peak was compared between treated and
control females to determine whether there was any temporal shift in the day of the mid-cycle
oestradiol peak. The duration of Phase II of the menstrual cycle between the treated and controls
was also studied and compared by Student's paired t tests.
Results
Menstrual cycles
All 10 solvent-treated controls exhibited ovulatory menstrual cycles and the mean cycle length
was about 26 days during the pretreatment, treatment and post-treatment periods (Table 1).
Menstruation in the controls was of normal duration (3-5 days).
Of the 17 norethisterone-treated animals, 7 showed ovulatory menstrual cycles which were of
normal duration and the remaining 10 showed anovulatory cycles. The cycle length in 4 of these 10
anovulatory monkeys was significantly (P < 0-01) reduced to about 17 days while in the other 6
anovulatory animals the cycle length was not different as compared with the controls. For conveni¬
ence of description the 4 anovulatory animals showing shortened cycles were considered as Group I
and the 6 anovulatory animals showing cycles of normal duration are included in Group II. The
post-treatment cycle length in some of the anovulatory animals was prolonged (Table 1).
Menstruation in all the norethisterone-treated animals was of normal duration during the
treatment and the post-treatment cycles.
Table 1. Menstrual cycle characteristics in female rhesus monkeys treated with norethisterone nasal
sprays
Day of Length of
Pretreatment Treatment oestradiol peak Phase II of Post-treatment
No. of cycle length cycle length in treatment treatment cycle cycle length
Treatment females (days) (days) cycle (days) (days)
None (controls) 10
Norethisterone
Anovulatory cycles
Group I 4
Group II 6
Ovulatory cycles 7
25-9±l-6 26-2±2-3
25-2 + 3-6 17-2 + 2-4***
(20-28) (14-19)
25-7±l-0
(24-27)
26-3 ±4-3(21-33)
27-2 ±1-6(24-28)
26-3 ±4-3
(21-33)
9-0+1-2
9-2 + 0-9
12-0+1-8***
11-5 + 2-8**
17-4+1-4
8-0+1-4***
15-2+1-7*
14-7+1-8***
26-6± 2-8
52-0 + 25-1(24-77)
32-2+ 9-7
(25-46)
28-0+ 41
(25-37)
Values are mean + s.d.; values in parentheses are ranges.
*
 < 001, **  < 002, ***  < 0001, compared with value for control females.
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Fig. 1. Changes in concentrations of hormones in (a) control females and (b) anovulatory cycles
in 10 norethisterone-treated (9 µg/day) female rhesus monkeys. Values are mean + s.e.m. and
have been normalized with reference to the peak of oestradiol (Day 0).
Hormonal changes
The hormonal profiles in blood samples taken daily throughout the cycle in the solvent-treated
controls (Fig. la) were not markedly different from those observed in normal ovulatory cycles in
monkeys kept in this colony (Anand Kumar et al., 1980b). In all the 17 treated monkeys the pattern
and circulating concentrations of oestradiol were similar to those seen in daily blood samples taken
throughout the cycle in the controls, indicating that follicular activity was not affected by
norethisterone treatment. In the 10 animals that exhibited anovulatory cycles the mid-cycle LH
peak value was markedly reduced and the circulating concentrations of progesterone remained
almost at basal levels even during Phase II of the cycle (Fig. lb), which is consistent with the
anovulation as revealed by laparoscopy. In the 7 ovulatory cycles observed in the
norethisterone-treated females, the hormonal patterns were not markedly different from those of
the controls.
Mean duration ofPhases I and II of the menstrual cycle
The oestradiol peak occurred around Day 9 of the cycle in all the solvent-treated controls and
the mean length of Phase II of the cycle was about 17 days. Except in the 4 anovulatory animals,
which showed shortened cycles (Group I), the onset of the oestradiol peak was significantly delayed
in most of the treated monkeys (Table 1 ). Phase II of the cycle in all the 17 treated animals was
significantly reduced as compared with the controls (Table 1).
Discussion
The present studies have shown that intranasal administration of norethisterone at a daily dose of
9 µg during the periovulatory period inhibited ovulation in 10 out of 17 treated rhesus monkeys.
The oestradiol-induced LH surge was also suppressed in these animals and progesterone remained
at basal levels. The hormonal patterns in the remaining 7 ovulatory cycles were indistinguishable
from those of the controls. The reason for this lack of a uniform effect, in terms of ovulation inhi¬
bition, is not known, but essentially similar findings have been reported for women treated with low
doses of norethisterone (Landgren & Diczfalusy, 1980).
The most consistent effect observed in the norethisterone-treated animals was the shortening of
the Phase II of the cycle, indicative of a shortened luteal phase. Shortening of the luteal phase of the
cycle has been shown to occur spontaneously in monkeys and women (diZerega & Hodgen, 1981)
and such shortened luteal phases are believed to be a result of alterations in the ratios of FSH:LH in
the blood during the cycle (Wilks, Hodgen & Ross, 1976). FSH concentrations were not measured
in the present studies because of difficulties in setting up accurate assays for measuring monkey
FSH in our laboratories without an appropriate FSH standard. However, since the mid-cycle peak
levels ofLH were markedly reduced in most of the treated animals, it is likely that FSH:LH ratios
were altered. It remains to be shown whether the treatment cycles exhibiting shortened luteal
phases are also infertile as has been suggested for naturally occurring cycles with shortened luteal
phases in women (diZerega & Hodgen, 1981).
The pharmacological effects observed in the present study have been well-documented for a
number of progestagens (Martinez-Manautou et al., 1966; Fotherby, 1977; Landgren & Diczfalusy,
1980). What is novel, however, is that these effects were observed by administering much lower
doses of the synthetic progestagen (— 2 µg per kg body weight) than currently used for adminis¬
tering norethisterone orally or systemically. The present studies therefore indicate that the
intranasal route of drug delivery could be used to advantage for reducing the dose of hormonal
contraceptives without a concomitant loss of efficacy.
This work was supported by the World Health Organisation, Geneva, and was carried out
during the award of the Jawaharlal Nehru Fellowship to T.C.A.K.
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